News

Partner companies' news

Ideanomics Announces State-of-the-Art EV Experience Center and U.S. Manufacturing Facility in New Jersey to Accelerate Commercial Electrification
NEW YORK , April 7, 2022 /PRNewswire/ -- Ideanomics [1] (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric...
Acorn Management Partners, Administrator
— April 2022 — 466 views IDEX

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
CELEBRATION, Fla., March 30, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— April 2022 — 454 views KMPH

Ideanomics Finalizes Energica Motor Company Deal, Acquiring 70 Percent Ownership Stake in Pioneering High-Performance All-Electric Motorcycle Company
NEW YORK , March 28, 2022 /PRNewswire/ --  Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric v...
Acorn Management Partners, Administrator
— March 2022 — 542 views IDEX

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference
CELEBRATION, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 477 views KMPH

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
CELEBRATION, Fla., March 21, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company or KemPharm), a specialty pharmaceutical company ...
Acorn Management Partners, Administrator
— March 2022 — 455 views KMPH

Ideanomics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
NEW YORK , March 18, 2022 /PRNewswire/ -- Ideanomics [1] (NASDAQ: IDEX) ("Ideanomics" or the "Company") today announced that it has received a not...
Acorn Management Partners, Administrator
— March 2022 — 483 views IDEX

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
CELEBRATION, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (the Company, or KemPharm), a specialty pharmaceutical company...
Acorn Management Partners, Administrator
— March 2022 — 433 views KMPH

Ideanomics Delays Filing of Annual Report on Form 10-K
NEW YORK, March 15, 2022 /PRNewswire/ --  Ideanomics [1] (NASDAQ: IDEX) ("Ideanomics" or the "Company") today announced that the filing of its Annu...
Acorn Management Partners, Administrator
— March 2022 — 460 views IDEX

KemPharm to Report Fourth Quarter and Full-Year 2021 Results
CELEBRATION, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery a...
Acorn Management Partners, Administrator
— March 2022 — 477 views KMPH

Ideanomics Secures Threshold in Energica Motor Company SpA Voluntary Tender Offer
NEW YORK, March 7, 2022 /PRNewswire/ -- (NASDAQ: IDEX) ("Ideanomics" or the "Company") is pleased to announce that it has provisionally passed the ...
Acorn Management Partners, Administrator
— March 2022 — 520 views IDEX

Ideanomics Provides Update on Timing of Fourth-Quarter and Full-Year 2021 Earnings Call
NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Ideanomics, Inc. (NASDAQ: IDEX) ("Ideanomics" or the "Company") will delay the release of its 2021 fourth-q...
Acorn Management Partners, Administrator
— February 2022 — 455 views IDEX

KemPharm Completes KP1077 Pre-IND Meeting Process with FDA
CELEBRATION, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— February 2022 — 462 views KMPH

Ideanomics to Announce Fourth-Quarter and Full-Year 2021 Earnings on March 1, 2022
NEW YORK, Jan. 31, 2022 /PRNewswire/ -- (NASDAQ: IDEX) ("Ideanomics" or the "Company") is pleased to announce the release of its 2021 fourth-quarte...
Acorn Management Partners, Administrator
— February 2022 — 550 views IDEX

Ideanomics to Speak on Three Panels at BloombergNEF Summit in San Francisco
SAN FRANCISCO, Jan. 26, 2022 /PRNewswire/ -- Ideanomics [1]  (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of el...
Acorn Management Partners, Administrator
— January 2022 — 519 views IDEX

KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy
CELEBRATION, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 446 views KMPH

KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion
CELEBRATION, Fla., Jan. 12, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 464 views KMPH

KemPharm Announces Research Involving Serdexmethylphenidate to be Featured in Two Poster Presentations at the APSARD 2022 Annual Conference
CELEBRATION, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 454 views KMPH

Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
FRAMINGHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 454 views ARTH

KemPharm to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2022”
CELEBRATION, Fla., Jan. 06, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery an...
Acorn Management Partners, Administrator
— January 2022 — 485 views KMPH

Arch Therapeutics Announces Appointment of Guy Fish to the Board
FRAMINGHAM, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 539 views ARTH

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives